Target intelligence / Profile preview

TMEM44 antisense RNA 2 (TMEM44-AS2)

Target
TMEM44-AS2
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

TMEM44 antisense RNA 2 (TMEM44-AS2) appears to be a hypothetical or uncharacterized long non-coding RNA transcribed antisense from the TMEM44 locus. No published studies define its function, biological role, disease relevance, or pharmacological tractability. By analogy, many antisense RNAs regulate gene expression through RNA-RNA or RNA-protein interactions and may have regulatory functions involved in gene silencing, activation, or mRNA stability. However, all currently published work and functional detail concerns TMEM44-AS1, not TMEM44-AS2. This likely means TMEM44-AS2 as a target is not currently tractable, and the query may result from a typographical error or premature gene annotation. Key point: If you are looking for the well-studied TMEM44 antisense non-coding RNA implicated in cancer, refer to TMEM44 antisense RNA 1 (TMEM44-AS1). If TMEM44-AS2 is a recently described or predicted transcript, there is no confirmed functional, therapeutic, or biomarker data available in the public biomedical literature.

02

Mechanism of action

None characterized; for lncRNAs/antisense RNAs broadly: gene silencing, mRNA stabilization, or epigenetic modulation

Beyond the preview

Go deeper on TMEM44 antisense RNA 2 (TMEM44-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM44 antisense RNA 2 (TMEM44-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call